Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.785
-0.095 (-1.95%)
Apr 25, 2025, 12:46 PM EDT - Market open
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $51.07 million as of April 25, 2025. Its market cap has increased by 340.22% in one year.
Market Cap
51.07M
Enterprise Value
-81.55M
1-Year Change
340.22%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $51.07M, an increase of 48.02%. That is a compound annual growth rate of 4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 52.10M | -32.51% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.90B |
| UnitedHealth Group | 388.35B |
| Johnson & Johnson | 380.90B |
| AbbVie | 306.71B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.80B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |